Business
‘Another string in our bow’: Novavax prepares for COVID-19 vaccine launch – Sydney Morning Herald
Maryland-based Novavax has finalised its deal with the Australian government for 51 million doses of its vaccine.
The technology behind Novavax’s coronavirus vaccine is different from other products that Australia has ordered. The protein-based candidate contains one element of the virus, a version of the “spike protein” in SARS-CoV-2, and the vaccine delivers this to the body to prompt an immune response.
Unlike mRNA vaccines like Pfizer’s, which must be stored at very low temperatures,Novavax’s product is designed to be more easily stored with standard refrigeration methods.
Novavax’s vaccine is in phase…
-
Noosa News23 hours agoCleveland line train services halted after truck crash at Pine Street bridge in Wynnum
-
General21 hours agoBrisbane homelessness services report 48 per cent increase in number of children being supported
-
Noosa News7 hours agoSoldiers airlifted to Townsville University Hospital after ADF crash
-
General19 hours agoFormer Alice Springs principal Gavin Morris guilty on four counts of aggravated assault against students